These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7978676)

  • 1. Nephrogenic diabetes insipidus secondary to lithium therapy in the postoperative patient: a case report.
    Johnson MA; Ogorman J; Golembiewski GH; Paluzzi MW
    Am Surg; 1994 Nov; 60(11):836-9. PubMed ID: 7978676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Standard perioperative management of patients treated with lithium can lead to hyperosmolar coma].
    Vergnaud E; Baudin O; Desachy A;
    Ann Fr Anesth Reanim; 2007 Feb; 26(2):168-70. PubMed ID: 17174064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of sodium depletion in acute antidiuretic effect of bendroflumethiazide in rats with nephrogenic diabetes insipidus.
    Janjua NR; Jonassen TE; Langhoff S; Thomsen K; Christensen S
    J Pharmacol Exp Ther; 2001 Oct; 299(1):307-13. PubMed ID: 11561093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative mechanisms of acute antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
    Moosavi SM; Haghani M
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1191-201. PubMed ID: 21164566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent nephrogenic diabetes insipidus following lithium therapy.
    Thompson CJ; France AJ; Baylis PH
    Scott Med J; 1997 Feb; 42(1):16-7. PubMed ID: 9226773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative mechanisms involved in chronic antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
    Moosavi SM; Karimi Z
    Acta Physiol Hung; 2014 Mar; 101(1):88-102. PubMed ID: 24631797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature.
    Jinnouchi T; Yoshimoto M; Ogino K; Oji T; Hayashi M
    Intern Med; 2024 May; 63(10):1399-1404. PubMed ID: 37779064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lithium-induced chronic water-metabolism disorder (nephrogenic diabetes insipidus)].
    Radó J; Zdravkova S
    Orv Hetil; 1991 Sep; 132(36):1987-90. PubMed ID: 1923471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
    Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC
    Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
    Li Y; Shaw S; Kamsteeg EJ; Vandewalle A; Deen PM
    J Am Soc Nephrol; 2006 Apr; 17(4):1063-72. PubMed ID: 16495377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus.
    Allen HM; Jackson RL; Winchester MD; Deck LV; Allon M
    Arch Intern Med; 1989 May; 149(5):1123-6. PubMed ID: 2719505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
    Joo KW; Jeon US; Kim GH; Park J; Oh YK; Kim YS; Ahn C; Kim S; Kim SY; Lee JS; Han JS
    Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired nephrogenic diabetes insipidus.
    Khanna A
    Semin Nephrol; 2006 May; 26(3):244-8. PubMed ID: 16713497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium intoxication-induced acute parkinsonism complicated with hyperparathyroidism and nephrogenic diabetes insipidus: report of a case.
    Shen HC; Li JY; Lo YK
    Acta Neurol Taiwan; 2007 Dec; 16(4):231-3. PubMed ID: 18220017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful rescue of severe hypernatraemia (196 mmol/L) by treatment with hypotonic fluid.
    Jeffery J; Ayling RM; McGonigle RJ
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):491-4. PubMed ID: 17761039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency treatment of lithium-induced diabetes insipidus with nonsteroidal anti-inflammatory drugs.
    Lam SS; Kjellstrand C
    Ren Fail; 1997 Jan; 19(1):183-8. PubMed ID: 9044466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism and severe hypernatremia in a patient with lithium-induced nephrogenic diabetes insipidus and acute kidney injury: a case report.
    Goo YJ; Song SH; Kwon OI; Kim M; Suh SH; Oh TR; Choi HS; Bae EH; Ma SK; Kim SW; Kim CS
    Ann Palliat Med; 2022 Aug; 11(8):2756-2760. PubMed ID: 34930011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perioperative management of a child with congenital nephrogenic diabetes insipidus].
    Mizushima T; Kitamura S; Kinouchi K; Taniguchi A; Fukumitsu K
    Masui; 2001 Mar; 50(3):287-9. PubMed ID: 11296443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hypernatraemia due to nephrogenic diabetes insipidus - a life-threatening side effect of chronic lithium therapy.
    Sze L; Ulrich B; Brändle M
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):596-8. PubMed ID: 17177143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium-induced nephrogenic diabetes insipidus.
    Stone KA
    J Am Board Fam Pract; 1999; 12(1):43-7. PubMed ID: 10050642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.